Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease

Abstract Background We investigated the potential associations between cerebro-spinal fluid (CSF) levels of phosphorylated tau (P-tau) and total tau (T-tau) with short-term response to cholinesterase inhibitor (ChEI) treatment, longitudinal outcome and progression rates in Alzheimer’s disease (AD)....

Full description

Bibliographic Details
Main Authors: Carina Wattmo, Kaj Blennow, Oskar Hansson
Format: Article
Language:English
Published: BMC 2020-01-01
Series:BMC Neurology
Subjects:
Alzheimer’s disease
Cholinesterase inhibitors
Cognition
Activities of daily living
Apolipoprotein E
Treatment effect
Online Access:https://doi.org/10.1186/s12883-019-1591-0

Internet

https://doi.org/10.1186/s12883-019-1591-0

Similar Items